bpc-157 safety and legality BPC 157 in Australia: Benefits, side effects, risks Rules and Risks of BPC-157

Yazaki Y, Chow G, Mattie M

A priori sample size and power calculations based on previous results from similar experiments 72,73 were performed to detect a minimum 3-fold increase of mean axon counts, a 50% increase in mean normalized CMAP amplitude, and a 50% reduction in mean normalized CMAP latency in the MSC-treated rats at the familywise error rate of 5% and 80% power

When conducting a review , one must look beyond marketing claims and examine the consistency of the batches provided to the public

Vesugen targets vascular tissue, which matters because accelerated atherosclerosis is a leading cause of morbidity and mortality in long-standing lupus